Publication|Articles|October 21, 2025
- Pharmaceutical Executive: October 2025
- Volume 45
- Issue 8
Pharmaceutical Executive: October 2025 Interactive Digital Edition
View the Pharmaceutical Executive October 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Price Checksabout 1 month ago
Bob Mauch: Strengthening the Chainabout 1 month ago
A Brave New World: Implications of the IRA on Brand Strategyabout 1 month ago
From ‘Pilotitis’ to Productivity: Reimagining AI’s Role in R&Dabout 1 month ago
Elevate Earned Media Through Continuing Educationabout 1 month ago
Navigating the Complexities of a Global Pharma ExpansionNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
FDA Announces Agency-Wide Deployment of Agentic AI Tools
4
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
5
